Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time Tradegate - 01/16 05:36:24 pm
9.054 EUR   +2.83%
2016 CYTOTOOLS : announces personnel change
2016 CYTOTOOLS : DermaTools action for damages
2016 CYTOTOOLS : DermaTools signs contracts for production by a new Germa..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
01/10/2017 01/11/2017 01/12/2017 01/13/2017 01/16/2017 Date
8.218(c) 8.485(c) 9.061(c) 8.805(c) 9.101 Last
837 196 11 185 3 004 11 299 Volume
-3.74% +3.25% +6.79% -2.83% +3.36% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -1,70 M
Net income 2015 -1,70 M
Finance 2015 3,30 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,70 M
Net income 2016 -1,70 M
Finance 2016 2,30 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales2015 9,54x
EV / Sales2016 5,89x
Capitalization 17,6 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which engages in developing therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
01/12 DGAP-NEWS : Die Gesellschafter der DermaTools Biotech GmbH stellen die Weichen f..
2016 CYTOTOOLS : announces personnel change
2016 DGAP-ADHOC : Die CytoTools AG gibt eine personelle Veränderung im Vorstand bekan..
2016 CYTOTOOLS : DermaTools action for damages
2016 DGAP-NEWS : CytoTools AG: Das Tochterunternehmen DermaTools Biotech GmbH reicht ..
2016 DGAP-NEWS : Wechsel im Aufsichtsrat der CytoTools AG - Herr Dr. Tober legt aus..
2016 DGAP-NEWS : CytoTools AG: Resultate aus der Phase II/III Studie zur Behandlung d..
2016 CYTOTOOLS : DermaTools signs contracts for production by a new German manufactur..
2016 DGAP-NEWS : DermaTools Biotech GmbH identifiziert neuen Hersteller für Wirkstoff..
2016 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Latest Tweets
2016CytoTools : DermaTools action for damages  
2016#Frankfurt #stocks: CytoTools : #Market Analysts conclude unsteady sales prof.. 
2016BRIEF-Cytotools unit signs contracts for production with German manufacturer ..
1
2016#Frankfurt #stocks: CytoTools : #Merger #Acquisition Analysts say: thin Feb 2.. 
2015#Frankfurt #stocks: CytoTools : #Market Analysts conclude dispiriting sales p.. 
More tweets
Qtime:50
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 €
Spread / Average Target 31%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark-Andre Freyberg CEO & Head-Investor Relations
Manfred May Chairman-Supervisory Board
Dirk Kaiser Chief Research Officer
Markus H. Weissbach Chief Medical Officer
Dieter Tober Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG2.40%19
AMGEN, INC.6.78%116 141
GILEAD SCIENCES, INC.2.04%96 267
CELGENE CORPORATION1.49%91 071
REGENERON PHARMACEUTIC..0.29%38 830
ACTELION LTD4.90%24 706
More Results